Literature DB >> 19693450

Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis.

Sumie Tabata1, Sonoko Shimoji1, Kimihiko Murase2, Yoko Takiuchi1, Daichi Inoue1, Takaharu Kimura1, Yuya Nagai1, Minako Mori1, Katsuhiro Togami1, Masayuki Kurata1, Kiminari Ito3, Hisako Hashimoto3, Akiko Matushita1, Kenichi Nagai1, Takayuki Takahashi4.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by the abnormal accumulation of alveolar surfactant protein in alveolar spaces. We report herein a rare case of myelodysplastic syndrome (MDS-RAEB) complicated by severe PAP, and successful allogeneic bone marrow transplantation (BMT) for both disorders. An unrelated BMT was planned for a 48-year-old male with advanced MDS-RAEB. Just before the initiation of the conditioning regimen for unrelated BMT in March 2007, he developed dyspnea. A diagnosis of PAP was made based on findings of chest X-ray, CT scanning, and the fluid obtained by bronchoalveolar lavage. To improve his dyspnea and improve BMT safety, whole lung lavage (WLL) was performed twice, with the partial improvement of PAP. Unrelated allogeneic BMT was performed in September 2007. We had to perform a third WLL because of the worsening of PAP on day 26 after BMT. Despite many infectious complications after BMT, GVHD was relatively mild. PAP had almost disappeared 6 months after BMT. He was well with favorable hematopoiesis 20 months after the BMT without any specific treatment. There has been no report of an MDS patient with PAP in whom 3 WLL procedures were performed before and after allogeneic BMT.

Entities:  

Mesh:

Year:  2009        PMID: 19693450     DOI: 10.1007/s12185-009-0404-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

1.  Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings.

Authors:  T Johkoh; H Itoh; N L Müller; K Ichikado; H Nakamura; J Ikezoe; M Akira; T Nagareda
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

2.  Successful cord blood transplantation for myelodysplastic syndrome resulting in resolution of pulmonary alveolar proteinosis.

Authors:  K Fukuno; A Tomonari; N Tsukada; S Takahashi; J Ooi; T Konuma; M Uchiyama; T Fujii; T Endo; A Iwamoto; N Oyaizu; K Nakata; H Moriwaki; A Tojo; S Asano
Journal:  Bone Marrow Transplant       Date:  2006-09-04       Impact factor: 5.483

3.  Haematopoietic transplantation in pulmonary alveolar proteinosis associated with chronic myelogenous leukaemia.

Authors:  M Rodríguez-Luaces; A Lafuente; M P Martín; P Mateos; E Ojeda; F Hernández-Navarro
Journal:  Bone Marrow Transplant       Date:  1997-09       Impact factor: 5.483

4.  Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.

Authors:  Ryushi Tazawa; Emi Hamano; Toru Arai; Hiromitsu Ohta; Osamu Ishimoto; Kanji Uchida; Masato Watanabe; Junichi Saito; Miki Takeshita; Yasuhiko Hirabayashi; Ikuo Ishige; Yoshinobu Eishi; Koichi Hagiwara; Masahito Ebina; Yoshikazu Inoue; Koh Nakata; Toshihiro Nukiwa
Journal:  Am J Respir Crit Care Med       Date:  2005-02-25       Impact factor: 21.405

5.  Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.

Authors:  U Dirksen; R Nishinakamura; P Groneck; U Hattenhorst; L Nogee; R Murray; S Burdach
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 6.  Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review.

Authors:  U B Prakash; S S Barham; H A Carpenter; D E Dines; H M Marsh
Journal:  Mayo Clin Proc       Date:  1987-06       Impact factor: 7.616

7.  Acquired pulmonary alveolar proteinosis after umbilical cord blood transplantation for acute myeloid leukemia.

Authors:  Akira Tomonari; Naoki Shirafuji; Tohru Iseki; Jun Ooi; Hitomi Nagayama; Atsuko Masunaga; Arinobu Tojo; Kenzaburo Tani; Shigetaka Asano
Journal:  Am J Hematol       Date:  2002-06       Impact factor: 10.047

Review 8.  Pulmonary alveolar proteinosis: progress in the first 44 years.

Authors:  John F Seymour; Jeffrey J Presneill
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

9.  Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis.

Authors:  Kelly J Butnor; Thomas A Sporn
Journal:  Arch Pathol Lab Med       Date:  2003-02       Impact factor: 5.534

10.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

View more
  8 in total

1.  Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease.

Authors:  Mari Tanaka-Kubota; Koji Shinozaki; Satoshi Miyamoto; Masakatsu Yanagimachi; Tsubasa Okano; Noriko Mitsuiki; Masahiro Ueki; Masafumi Yamada; Kohsuke Imai; Masatoshi Takagi; Kazunaga Agematsu; Hirokazu Kanegane; Tomohiro Morio
Journal:  Int J Hematol       Date:  2017-11-28       Impact factor: 2.490

2.  Pulmonary Alveolar Proteinosis due to Familial Myelodysplastic Syndrome with resolution after stem cell transplant.

Authors:  Amjad Basheer; Eduardo Messias Hirano Padrao; Kangwook Huh; Susan Parker; Tejal Shah; Daniel A Gerardi
Journal:  Autops Case Rep       Date:  2022-05-13

Review 3.  Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review).

Authors:  Dongmei Zhang; Xinlun Tian; Ruie Feng; Xiaobei Guo; Peng Wang; Yusen Situ; Yi Xiao; Kai-Feng Xu
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

4.  Clinical features of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome: Two case reports.

Authors:  Yin Liu; Lu Lu Chen; Yu Ying Qiu; Yong Long Xiao; Hou Rong Cai
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

5.  Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome.

Authors:  Miki Hashimoto; Hidehiro Itonaga; Yasuhito Nannya; Hirokazu Taniguchi; Yuichi Fukuda; Takafumi Furumoto; Machiko Fujioka; Sachie Kasai; Masataka Taguchi; Hiroaki Taniguchi; Shinya Sato; Yasushi Sawayama; Sunao Atogami; Keisuke Iwasaki; Tomoko Hata; Hiroshi Soda; Yukiyoshi Moriuchi; Koh Nakata; Seishi Ogawa; Yasushi Miyazaki
Journal:  Intern Med       Date:  2019-12-26       Impact factor: 1.271

6.  Chronic myelomonocytic leukemia-associated pulmonary alveolar proteinosis: A case report and review of literature.

Authors:  Can Chen; Xi-Lian Huang; Da-Quan Gao; Yi-Wei Li; Shen-Xian Qian
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

7.  Intestinal Behçet's disease complicated by myelodysplastic syndrome and secondary pulmonary alveolar proteinosis: a case report.

Authors:  Hiroshi Shimizu; Shuzo Sato; Tomohiro Suzuki; Tomomi Sasajima; Yosuke Takahata; Nobuhiko Shinohara; Kosuke Hideshima; Yuko Yokokawa; Nobuo Matsuhashi; Osamu Ichii; Mayumi Tai; Yutaka Ejiri; Kiori Yano; Takayuki Ikezoe; Hiromasa Ohira; Kiyoshi Migita
Journal:  BMC Gastroenterol       Date:  2021-12-20       Impact factor: 3.067

8.  Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.

Authors:  Haruyuki Ishii; John F Seymour; Ryushi Tazawa; Yoshikazu Inoue; Naoyuki Uchida; Aya Nishida; Yoshihito Kogure; Takeshi Saraya; Keisuke Tomii; Toshinori Takada; Yuko Itoh; Masayuki Hojo; Toshio Ichiwata; Hajime Goto; Koh Nakata
Journal:  BMC Pulm Med       Date:  2014-03-05       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.